Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Final Trades: Oracle, Vertiv Holdings and GSK
01:28pm, Friday, 06'th Dec 2024
The Investment Committee give you their top stocks to watch for the second half.
GSK Expands Vaccine Collaboration With Zhifei in China
12:55pm, Thursday, 05'th Dec 2024
GSK expands the licensing deal with Zhifei to market its shingles vaccine in China for an additional eight years till 2034.
GSK extends vaccine partnership with Zhifei in China
03:51am, Thursday, 05'th Dec 2024
GSK PLC (LSE:GSK, NYSE:GSK) has extended its partnership with Chongqing Zhifei Biological Products (Zhifei) to bring its shingles vaccine, Shingrix, to mainland China through 2034. The revised agreeme
GSK, China's Zhifei Expand Shingles Shot Collaboration
03:40am, Thursday, 05'th Dec 2024
GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.
GSK expands deal with China's Zhifei to explore RSV vaccine collaboration
02:29am, Thursday, 05'th Dec 2024
GSK said on Thursday it has expanded its agreement with China's Zhifei to explore a collaboration with the Chinese vaccines company on the British drugmaker's respiratory syncytial virus (RSV) vaccine
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
11:26am, Thursday, 28'th Nov 2024
The European Commission approves fully liquid presentation of GSK's meningococcal vaccine, Menveo, to protect against invasive meningococcal disease.
Anson Resources unique chemical-free lithium brine pre-treatment used in successful DLE testing
06:45am, Wednesday, 27'th Nov 2024
Anson Resources Ltd (ASX:ASN, OTCQB:ANSNF) has successfully tested its chemical-free lithium brine pre-treatment process that reduces iron in brine, with the iron-free brine successfully used as feed
GSK's receives European Commission green light for liquid form of key vaccine
03:07am, Wednesday, 27'th Nov 2024
GSK PLC (LSE:GSK, NYSE:GSK) has received approval from the European Commission for a new, fully liquid version of its Menveo vaccine, which protects against invasive meningococcal disease (IMD) cause
FDA Accepts GSK's BLA for Blenrep Combos in Multiple Myeloma
11:25am, Tuesday, 26'th Nov 2024
The FDA accepts GSK's BLA seeking approval of Blenrep combinations for treating relapsed/refractory multiple myeloma. A decision is due on July 23, 2025.
GSK submits multiple myeloma treatment for approval to the US regulator
03:01am, Monday, 25'th Nov 2024
The US Food and Drug Administration (FDA) has accepted GSK PLC (LSE:GSK, NYSE:GSK)'s application to review the use of Blenrep (belantamab mafodotin) in treating relapsed or refractory multiple myeloma
GSK's RSV vaccine gets greenlight in Japan
04:07am, Friday, 22'nd Nov 2024
GSK PLC (LSE:GSK, NYSE:GSK) has announced that Japan's Ministry of Health, Labour and Welfare has approved its RSV vaccine, Arexvy, for use in adults aged 50-59 at increased risk of severe RSV-related
GSK’s RSV vaccine gets greenlight in Japan
04:06am, Friday, 22'nd Nov 2024
GSK PLC (LSE:GSK, NYSE:GSK) has announced that Japan’s Ministry of Health, Labour and Welfare has approved its RSV vaccine, Arexvy, for use in adults aged 50-59 at increased risk of severe RSV-relat
GSK's RSV vaccine gets Japan approval for adults aged 50 to 59
02:50am, Friday, 22'nd Nov 2024
GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in adults aged between 50 and 59, who are at increased risk of severe RSV disease.
GSK Drug for Rare Disease-Related Itch Meets Goal in Phase III Study
12:00pm, Wednesday, 20'th Nov 2024
The GLISTEN study evaluating GSK's candidate, linerixibat, for treating cholestatic pruritus related to primary biliary cholangitis meets the primary endpoint.
GSK share price is imploding: is it safe to buy the dip?
04:05am, Tuesday, 19'th Nov 2024
The GSK share price has been in a strong freefall after peaking at 1,785p in September. Most recently, the GSK stock retreated for five consecutive weeks and reached its lowest level since October las
